As of Oct 09
| -0.11 / -1.26%|
The 5 analysts offering 12-month price forecasts for Theravance Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +50.46% increase from the last price of 8.64.
The current consensus among 6 polled investment analysts is to Hold stock in Theravance Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.